+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Equine Artificial Insemination Market Size, Share & Trends Analysis Report by Solution (Equipment & Consumables, Semen, Services), Equine (Sports/Racing, Recreation), Distribution Channel, and Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 150 Pages
  • September 2025
  • Region: United States
  • Grand View Research
  • ID: 6176731
The U.S. equine artificial insemination market size was estimated at USD 162.61 Million in 2025 and is projected to reach USD 247.83 million by 2033, growing at a CAGR of 5.41% from 2025 to 2033. The market is continuously growing, driven by the rising popularity of performance and recreational horses, expanding equine veterinary infrastructure, and a supportive regulatory and breeding industry ecosystem. The professional racing and competition, the growing popularity of recreational riding, show jumping, and Western performance events, are driving demand for high-quality horses in the U.S. The U.S. is home to around 9.2 million horses, playing a vital role in recreation, competition, and the broader equine industry. Among this population, nearly 3.9 million are engaged in recreational activities, while about 2.7 million participate in horse shows, reflecting the strong cultural and economic importance of equestrian pursuits nationwide.

Owners are increasingly investing in artificial insemination (AI) to secure foals with superior genetics for endurance, agility, and temperament. This demand spans disciplines such as rodeo, barrel racing, hunter/jumper circuits, and dressage. By enabling wider access to proven stallions, AI supports the breeding of horses suited to diverse performance needs. The expanding recreational equine sector, particularly in states like Texas, Kentucky, and California, continues to boost AI adoption.

U.S. Equine Artificial Insemination Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. equine artificial insemination market report based on solution, equine, and distribution channel:

Solution Outlook (Revenue, USD Million, 2021-2033)

  • Equipment & Consumables
  • Semen
  • Services

Equine Outlook (Revenue, USD Million, 2021-2033)

  • Sports/Racing
  • Recreation
  • Other Type

Distribution Channel Outlook (Revenue, USD Million, 2021-2033)

  • Private
  • Public

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.3.6. Data analysis model
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Equine Artificial Insemination Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Expanding equine veterinary infrastructure
3.2.1.2. Rising popularity of performance and recreational horses
3.2.1.3. Supportive regulatory and breeding industry ecosystem
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of advanced reproductive procedures.
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. U.S. Equine Artificial Insemination Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Legal landscape
3.3.2.3. Economic landscape
3.3.2.4. Social landscape
3.3.2.5. Technological landscape
3.3.2.6. Environmental landscape
3.4. Pricing Analysis
3.5. Regulatory Framework
3.6. Estimated Equine Population by key countries, 2024
Chapter 4. U.S. Equine Artificial Insemination Market: Solution Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Equine Artificial Insemination Market: Solution Movement Analysis
4.3. U.S. Equine Artificial Insemination Market Size & Trend Analysis, by solution, 2021 to 2033 (USD Million)
4.4. Equipment & Consumables
4.4.1. Equipment & Consumables Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Semen
4.5.1. Semen Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.1.1. Normal Semen
4.5.1.1.1. Normal Semen Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.1.2. Sexed Semen
4.5.1.2.1. Sexed Semen Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Services
4.6.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. U.S. Equine Artificial Insemination Market: Equine Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Equine Artificial Insemination Market: Equine Movement Analysis
5.3. U.S. Equine Artificial Insemination Market Size & Trend Analysis, by Equine, 2021 to 2033 (USD Million)
5.4. Sports/Racing
5.4.1. Sports/Racing Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Recreation
5.5.1. Recreation Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. U.S. Equine Artificial Insemination Market: by Distribution Channel Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Equine Artificial Insemination Market: by Distribution Channel Movement Analysis
6.3. U.S. Equine Artificial Insemination Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
6.3.1. Private
6.3.1.1. Private Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.3.2. Public
6.3.2.1. Public Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Company Market Position Analysis/ Heat Map Analysis
7.3. Company Profiles
7.3.1. Neogen Corporation
7.3.1.1. Participant’s Overview
7.3.1.2. Financial Performance
7.3.1.3. Product/Service Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Zoetis Services LLC
7.3.2.1. Participant’s Overview
7.3.2.2. Financial Performance
7.3.2.3. Product/Service Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. HOFFMAN A.I. BREEDERS INC
7.3.3.1. Participant’s Overview
7.3.3.2. Financial Performance
7.3.3.3. Product/Service Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. Nasco Healthcare
7.3.4.1. Participant’s Overview
7.3.4.2. Financial Performance
7.3.4.3. Product/Service Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. IMV Technologies
7.3.5.1. Participant’s Overview
7.3.5.2. Financial Performance
7.3.5.3. Product/Service Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. Continental Genetics, LLC
7.3.6.1. Participant’s Overview
7.3.6.2. Financial Performance
7.3.6.3. Product/Service Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. Olympia Equine Veterinary Services PLLC
7.3.7.1. Participant’s Overview
7.3.7.2. Financial Performance
7.3.7.3. Product/Service Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. Sarasota Equine Veterinary Services
7.3.8.1. Participant’s Overview
7.3.8.2. Financial Performance
7.3.8.3. Product/Service Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. Montana Equine Medical and Surgical Center
7.3.9.1. Participant’s Overview
7.3.9.2. Financial Performance
7.3.9.3. Product/Service Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. Select Breeders Services
7.3.10.1. Participant’s Overview
7.3.10.2. Financial Performance
7.3.10.3. Product/Service Benchmarking
7.3.10.4. Strategic Initiatives
7.3.11. Equine Reproduction Concepts, LLC
7.3.11.1. Participant’s Overview
7.3.11.2. Financial Performance
7.3.11.3. Product/Service Benchmarking
7.3.11.4. Strategic Initiatives
7.3.12. Wisconsin Valley Veterinary Service
7.3.12.1. Participant’s Overview
7.3.12.2. Financial Performance
7.3.12.3. Product/Service Benchmarking
7.3.12.4. Strategic Initiatives
7.4. Strategy Mapping
7.4.1. Mergers & Acquisitions
7.4.2. Partnerships & Collaborations
7.4.3. Product/Service launch
7.4.4. Others
7.5. List of other key players
List of Tables
Table 1 List of secondary sources
Table 2 U.S. Equine Artificial Insemination Market, by Solution, 2021-2033 (USD Million)
Table 3 U.S. Equine Artificial Insemination Market, by Equine, 2021-2033 (USD Million)
Table 4 U.S. Equine Artificial Insemination Market, by Distribution Channel, 2021-2033 (USD Million)
Table 5 Company Overview
Table 6 Product Benchmarking
Table 7 Financial Performance
Table 8 Strategic Initiatives
List of Figures
Figure 1 Market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value chain-based sizing & forecasting
Figure 7 QFD modelling for market share assessment
Figure 8 Market formulation & validation
Figure 9 U.S. Equine Artificial Insemination Market revenue, 2021-2033 (USD Million)
Figure 10 U.S. Equine Artificial Insemination Market snapshot
Figure 11 U.S. Equine Artificial Insemination Market driver impact
Figure 12 U.S. Equine Artificial Insemination Market restraint impact
Figure 13 U.S. Equine Artificial Insemination species key takeaways (USD Million)
Figure 14 U.S. Equine Artificial Insemination Market: solution, market share 2024 & 2033
Figure 15 U.S. Equipment & Consumables market, 2021-2033 (USD Million)
Figure 16 Semen market, 2021-2033 (USD Million)
Figure 17 Normal market, 2021-2033 (USD Million)
Figure 18 Sexed market, 2021-2033 (USD Million)
Figure 19 Services market, 2021-2033 (USD Million)
Figure 20 U.S. Equine Artificial Insemination equine key takeaways (USD Million)
Figure 21 U.S. Equine Artificial Insemination Market: equine, market share 2024 & 2033
Figure 22 Sports/Racing market, 2021-2033 (USD Million)
Figure 23 Recreation market, 2021-2033 (USD Million)
Figure 24 Others market, 2021-2033 (USD Million)
Figure 25 U.S. Equine Artificial Insemination market by Distribution Channel: Key takeaways
Figure 26 U.S. Equine Artificial Insemination market by Distribution Channel, market share, 2024 & 2033
Figure 27 Private market, 2021-2033 (USD Million)
Figure 28 Public market, 2021-2033 (USD Million)
Figure 29 Market participant categorization
Figure 30 Market share of key market players U.S. Equine Artificial Insemination market

Companies Mentioned

The leading players profiled in this U.S. Equine Artificial Insemination market report include:
  • eogen Corporation
  • oetis Services LLC
  • OFFMAN A.I. BREEDERS INC
  • asco Healthcare.
  • MV Technologies
  • ontinental Genetics, LLC.
  • lympia Equine Veterinary Services PLLC
  • arasota Equine Veterinary Services
  • ontana Equine Medical and Surgical Center
  • elect Breeders Services
  • quine Reproduction Concepts, LLC.
  • isconsin Valley Veterinary Service

Table Information